are now
Press Release
Nexelis acquires the GSK vaccines clinical bioanalytical laboratory located in Marburg – Germany and enters into a 5-year strategic agreement with GSK
20 Jan 2021 | Press Release
Laval, Quebec, and Marburg, Germany, January 20, 2021. Nexelis, a portfolio company of Ampersand Capital Partners, and a leading provider […]
CEPI establishes global network of laboratories to centralise assessment of COVID-19 vaccine candidates
02 Oct 2020 | Press Release
Five laboratories initially selected to work together as part of centralised network to reliably assess and compare immunological responses generated […]
Nexelis Acquires Integrated Bioanalytical CRO AIT Bioscience
July 22, 2020 | Press Release
Laval, Quebec, and Indianapolis, IN, July 22, 2020 – Nexelis, a portfolio company of Ampersand Capital Partners and a leading […]
Nexelis to Acquire Specialty Immunogenicity and Immune-Oncology Testing Laboratory ImmunXperts
March 4, 2020 | Press Release
Laval, Quebec, and Gosselies, Belgium, March 04, 2020 – Nexelis, a portfolio company of Ampersand Capital Partners, and a leading […]